|
1
|
Blechacz B and Gores GJ:
Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and
treatment. Hepatology. 48:308–321. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Welzel TM, McGlynn KA, Hsing AW, O'Brien
TR and Pfeiffer RM: Impact of classification of hilar
cholangiocarcinomas (Klatskin tumors) on the incidence of intra-
and extrahepatic cholangiocarcinoma in the United States. J Natl
Cancer Inst. 98:873–875. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Farley DR, Weaver AL and Nagorney DM:
‘Natural history’ of unresected cholangiocarcinoma: Patient outcome
after noncurative intervention. Mayo Clin Proc. 70:pp. 425–429.
1995; View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Anderson CD, Pinson CW, Berlin J and Chari
RS: Diagnosis and treatment of cholangiocarcinoma. Oncologist.
9:43–57. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sripa B, Brindley PJ, Mulvenna J, Laha T,
Smout MJ, Mairiang E, Bethony JM and Loukas A: The tumorigenic
liver fluke Opisthorchis viverrini-multiple pathways to cancer.
Trends Parasitol. 28:395–407. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sripa B, Kaewkes S, Sithithaworn P,
Mairiang E, Laha T, Smout M, Pairojkul C, Bhudhisawasdi V, Tesana
S, Thinkamrop B, et al: Liver fluke induces cholangiocarcinoma.
PLoS Med. 4:e2012007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Weigelt B, Peterse JL and van't Veer LJ:
Breast cancer metastasis: Markers and models. Nat Rev Cancer.
5:591–602. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Heerboth S, Housman G, Leary M, Longacre
M, Byler S, Lapinska K, Willbanks A and Sarkar S: EMT and tumor
metastasis. Clin Transl Med. 4:62015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nieto MA: Epithelial plasticity: A common
theme in embryonic and cancer cells. Science. 342:12348502013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Moreno-Bueno G, Portillo F and Cano A:
Transcriptional regulation of cell polarity in EMT and cancer.
Oncogene. 27:6958–6969. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Peinado H, Olmeda D and Cano A: Snail, Zeb
and bHLH factors in tumour progression: An alliance against the
epithelial phenotype? Nat Rev Cancer. 7:415–428. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Adhikary A, Chakraborty S, Mazumdar M,
Ghosh S, Mukherjee S, Manna A, Mohanty S, Nakka KK, Joshi S, De A,
et al: Inhibition of epithelial to mesenchymal transition by
E-cadherin up-regulation via repression of slug transcription and
inhibition of E-cadherin degradation: Dual role of scaffold/matrix
attachment region-binding protein 1 (SMAR1) in breast cancer cells.
J Biol Chem. 289:25431–25444. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Techasen A, Loilome W, Namwat N, Khuntikeo
N, Puapairoj A, Jearanaikoon P, Saya H and Yongvanit P: Loss of
E-cadherin promotes migration and invasion of cholangiocarcinoma
cells and serves as a potential marker of metastasis. Tumour Biol.
35:8645–8652. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mendez MG, Kojima S and Goldman RD:
Vimentin induces changes in cell shape, motility, and adhesion
during the epithelial to mesenchymal transition. FASEB J.
24:1838–1851. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chaw SY, Majeed AA, Dalley AJ, Chan A,
Stein S and Farah CS: Epithelial to mesenchymal transition (EMT)
biomarkers-E-cadherin, beta-catenin, APC and Vimentin-in oral
squamous cell carcinogenesis and transformation. Oral Oncol.
48:997–1006. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Qiu W, David D, Zhou B, Chu PG, Zhang B,
Wu M, Xiao J, Han T, Zhu Z, Wang T, et al: Down-regulation of
growth arrest DNA damage-inducible gene 45beta expression is
associated with human hepatocellular carcinoma. Am J Pathol.
162:1961–1974. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zumbrun SD, Hoffman B and Liebermann DA:
Distinct mechanisms are utilized to induce stress sensor gadd45b by
different stress stimuli. J Cell Biochem. 108:1220–1231. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liebermann DA and Hoffman B: Gadd45 in
stress signaling. J Mol Signal. 3:152008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Vairapandi M, Balliet AG, Fornace AJ Jr,
Hoffman B and Liebermann DA: The differentiation primary response
gene MyD118, related to GADD45, encodes for a nuclear protein which
interacts with PCNA and p21WAF1/CIP1. Oncogene. 12:2579–2594.
1996.PubMed/NCBI
|
|
20
|
Smith ML, Ford JM, Hollander MC, Bortnick
RA, Amundson SA, Seo YR, Deng CX, Hanawalt PC and Fornace AJ Jr:
p53-mediated DNA repair responses to UV radiation: Studies of mouse
cells lacking p53, p21, and/or gadd45 genes. Mol Cell Biol.
20:3705–3714. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jónsson ZO and Hübscher U: Proliferating
cell nuclear antigen: More than a clamp for DNA polymerases.
Bioessays. 19:967–975. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kelman Z and Hurwitz J: Protein-PCNA
interactions: A DNA-scanning mechanism? Trends Biochem Sci.
23:236–238. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Leprivier G, Rotblat B, Khan D, Jan E and
Sorensen PH: Stress-mediated translational control in cancer cells.
Biochim Biophys Acta. 1849:845–860. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Qiu W, Zhou B, Zou H, Liu X, Chu PG, Lopez
R, Shih J, Chung C and Yen Y: Hypermethylation of growth arrest DNA
damage-inducible gene 45 beta promoter in human hepatocellular
carcinoma. Am J Pathol. 165:1689–1699. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang L, Xiao X, Li D, Chi Y, Wei P, Wang
Y, Ni S, Tan C, Zhou X and Du X: Abnormal expression of GADD45B in
human colorectal carcinoma. J Transl Med. 10:2152012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Meir T, Dror R, Yu X, Qian J, Simon I,
Pe'er J and Chowers I: Molecular characteristics of liver
metastases from uveal melanoma. Invest Ophthalmol Vis Sci.
48:4890–4896. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Inowa T, Hishikawa K, Matsuzaki Y, Isagawa
T, Takeuchi T, Aburatani H, Kitamura T and Fujita T: GADD45β
determines chemoresistance and invasive growth of side population
cells of human embryonic carcinoma. Stem Cells Int.
2010:7829672010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sirisinha S, Tengchaisri T, Boonpucknavig
S, Prempracha N, Ratanarapee S and Pausawasdi A: Establishment and
characterization of a cholangiocarcinoma cell line from a Thai
patient with intrahepatic bile duct cancer. Asian Pac J Allergy
Immunol. 9:153–157. 1991.PubMed/NCBI
|
|
29
|
Pongcharoen P, Jinawath A and Tohtong R:
Silencing of CD44 by siRNA suppressed invasion, migration and
adhesion to matrix, but not secretion of MMPs, of
cholangiocarcinoma cells. Clin Exp Metastasis. 28:827–839. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Schneider CA, Rasband WS and Eliceiri KW:
NIH Image to ImageJ: 25 years of image analysis. Nat Methods.
9:671–675. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li YH and Zhu C: A modified Boyden chamber
assay for tumor cell transendothelial migration in vitro.
Clin Exp Metastasis. 17:423–429. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Uhlen M, Fagerberg L, Hallström BM,
Lindskog C, Oksvold P, Mardinoglu A, Sivertsson Å, Kampf C,
Sjöstedt E, Asplund A, et al: Proteomics. Tissue-based map of the
human proteome. Science. 347:12604192015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kerr JF, Wyllie AH and Currie AR:
Apoptosis: A basic biological phenomenon with wide-ranging
implications in tissue kinetics. Br J Cancer. 26:239–257. 1972.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tewari M, Quan LT, O'Rourke K, Desnoyers
S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS and Dixit VM:
Yama/CPP32 beta, a mammalian homolog of CED-3, is a
CrmA-inhibitable protease that cleaves the death substrate
poly(ADP-ribose) polymerase. Cell. 81:801–809. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kumar A, Rajendran V, Sethumadhavan R and
Purohit R: Akt kinase pathway: A leading target in cancer research.
ScientificWorldJournal. 2013:7561342013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Nebreda AR and Porras A: p38 MAP kinases:
Beyond the stress response. Trends Biochem Sci. 25:257–260. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kyriakis JM and Avruch J: Mammalian
mitogen-activated protein kinase signal transduction pathways
activated by stress and inflammation. Physiol Rev. 81:807–869.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Erhardt P, Schremser EJ and Cooper GM:
B-Raf inhibits programmed cell death downstream of cytochrome c
release from mitochondria by activating the MEK/Erk pathway. Mol
Cell Biol. 19:5308–5315. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Talmadge JE and Fidler IJ: AACR centennial
series: The biology of cancer metastasis: Historical perspective.
Cancer Res. 70:5649–5669. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Mehlen P and Puisieux A: Metastasis: A
question of life or death. Nat Rev Cancer. 6:449–458. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Davies KJ: The complex interaction of
matrix metalloproteinases in the migration of cancer cells through
breast tissue Stroma. Int J Breast Cancer. 2014:8390942014.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Roomi MW, Monterrey JC, Kalinovsky T, Rath
M and Niedzwiecki A: Patterns of MMP-2 and MMP-9 expression in
human cancer cell lines. Oncol Rep. 21:1323–1333. 2009.PubMed/NCBI
|
|
44
|
Micalizzi DS, Farabaugh SM and Ford HL:
Epithelial-mesenchymal transition in cancer: Parallels between
normal development and tumor progression. J Mammary Gland Biol
Neoplasia. 15:117–134. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Powell DR, Blasky AJ, Britt SG and
Artinger KB: Riding the crest of the wave: Parallels between the
neural crest and cancer in epithelial-to-mesenchymal transition and
migration. Wiley Interdiscip Rev Syst Biol Med. 5:511–522. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wallerand H, Cai Y, Wainberg ZA, Garraway
I, Lascombe I, Nicolle G, Thiery JP, Bittard H, Radvanyi F and
Reiter RR: Phospho-Akt pathway activation and inhibition depends on
N-cadherin or phospho-EGFR expression in invasive human bladder
cancer cell lines. Urol Oncol. 28:180–188. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Furuse M, Fujita K, Hiiragi T, Fujimoto K
and Tsukita S: Claudin-1 and −2: Novel integral membrane proteins
localizing at tight junctions with no sequence similarity to
occludin. J Cell Biol. 141:1539–1550. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Stevenson BR, Siliciano JD, Mooseker MS
and Goodenough DA: Identification of ZO-1: A high molecular weight
polypeptide associated with the tight junction (zonula occludens)
in a variety of epithelia. J Cell Biol. 103:755–766. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Rørth P: Collective cell migration. Annu
Rev Cell Dev Biol. 25:407–429. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Gupta M, Gupta SK, Balliet AG, Hollander
MC, Fornace AJ, Hoffman B and Liebermann DA: Hematopoietic cells
from Gadd45a- and Gadd45b-deficient mice are sensitized to
genotoxic-stress-induced apoptosis. Oncogene. 24:7170–7179. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
De Smaele E, Zazzeroni F, Papa S, Nguyen
DU, Jin R, Jones J, Cong R and Franzoso G: Induction of gadd45beta
by NF-kappaB downregulates pro-apoptotic JNK signalling. Nature.
414:308–313. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Zazzeroni F, Papa S, Algeciras-Schimnich
A, Alvarez K, Melis T, Bubici C, Majewski N, Hay N, De Smaele E,
Peter ME and Franzoso G: Gadd45 beta mediates the protective
effects of CD40 costimulation against Fas-induced apoptosis. Blood.
102:3270–3279. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Yothaisong S, Dokduang H, Techasen A,
Namwat N, Yongvanit P, Bhudhisawasdi V, Puapairoj A, Riggins GJ and
Loilome W: Increased activation of PI3K/Akt signaling pathway is
associated with cholangiocarcinoma metastasis and PI3K/mTOR
inhibition presents a possible therapeutic strategy. Tumour Biol.
34:3637–3648. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Salerno DM, Tront JS, Hoffman B and
Liebermann DA: Gadd45a and Gadd45b modulate innate immune functions
of granulocytes and macrophages by differential regulation of p38
and JNK signaling. J Cell Physiol. 227:3613–3620. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Kodama S and Negishi M: Pregnane X
receptor PXR activates the GADD45beta gene, eliciting the p38 MAPK
signal and cell migration. J Biol Chem. 286:3570–3578. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Medici D, Hay ED and Olsen BR: Snail and
Slug promote epithelial-mesenchymal transition through
beta-catenin-T-cell factor-4-dependent expression of transforming
growth factor-beta3. Mol Biol Cell. 19:4875–4887. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Vuoriluoto K, Haugen H, Kiviluoto S,
Mpindi JP, Nevo J, Gjerdrum C, Tiron C, Lorens JB and Ivaska J:
Vimentin regulates EMT induction by Slug and oncogenic H-Ras and
migration by governing Axl expression in breast cancer. Oncogene.
30:1436–1448. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Kim JY, Kim YM, Yang CH, Cho SK, Lee JW
and Cho M: Functional regulation of Slug/Snail2 is dependent on
GSK-3β-mediated phosphorylation. FEBS J. 279:2929–2939. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Cross DA, Alessi DR, Vandenheede JR,
McDowell HE, Hundal HS and Cohen P: The inhibition of glycogen
synthase kinase-3 by insulin or insulin-like growth factor 1 in the
rat skeletal muscle cell line L6 is blocked by wortmannin, but not
by rapamycin: Evidence that wortmannin blocks activation of the
mitogen-activated protein kinase pathway in L6 cells between Ras
and Raf. Biochem J. 303:21–26. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Bezdekova M, Brychtova S, Sedlakova E,
Langova K, Brychta T and Belej K: Analysis of Snail-1, E-cadherin
and claudin-1 expression in colorectal adenomas and carcinomas. Int
J Mol Sci. 13:1632–1643. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Stebbing J, Filipovic A and Giamas G:
Claudin-1 as a promoter of EMT in hepatocellular carcinoma.
Oncogene. 32:4871–4872. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Oliveira SS and Morgado-Diaz JA: Claudins:
Multifunctional players in epithelial tight junctions and their
role in cancer. Cell Mol Life Sci. 64:17–28. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Kwon MJ: Emerging roles of claudins in
human cancer. Int J Mol Sci. 14:18148–18180. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Bauer H, Zweimueller-Mayer J, Steinbacher
P, Lametschwandtner A and Bauer HC: The dual role of zonula
occludens (ZO) proteins. J Biomed Biotechnol. 2010:4025932010.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Gottardi CJ, Arpin M, Fanning AS and
Louvard D: The junction-associated protein, zonula occludens-1,
localizes to the nucleus before the maturation and during the
remodeling of cell-cell contacts. Proc Natl Acad Sci USA. 93:pp.
10779–10784. 1996; View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Smalley KS, Brafford P, Haass NK, Brandner
JM, Brown E and Herlyn M: Up-regulated expression of zonula
occludens protein-1 in human melanoma associates with N-cadherin
and contributes to invasion and adhesion. Am J Pathol.
166:1541–1554. 2005. View Article : Google Scholar : PubMed/NCBI
|
